Related Experiment Video
Updated: Jul 17, 2025
11:19
Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms
Published on: April 11, 2017
13.5K
Primary Human Cell-Derived Extracellular Matrix from Decellularized Fibroblast Microtissues with Tissue-Dependent
Biorxiv : the Preprint Server for Biology
|August 30, 2023
Summary
Researchers developed a method to create human extracellular matrix (ECM) from fibroblasts in microtissues. This decellularized ECM retains tissue and disease-specific features for potential therapeutic applications.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Cell Biology
Background:
- Human extracellular matrix (ECM) complexity presents challenges in reverse engineering.
- Fibroblast-secreted ECM is a promising acellular biomaterial source.
- Standard culture conditions impart aberrant mechanical cues affecting ECM deposition.
Approach:
- Engineered microtissues from primary human fibroblasts in low-adhesion microwells.
- Optimized culture and decellularization protocols for producing human ECM.
- Investigated cardiac and lung fibroblasts from healthy and diseased donors.
Key Points:
- Characterized gene expression, protein composition, microstructure, and mechanical properties of the decellularized ECM.
- Demonstrated successful ECM production from both cardiac and lung fibroblasts.
- Highlighted the ability to capture tissue- and disease-specific ECM characteristics.
Conclusions:
- Developed a method for biomanufacturing patient- and tissue-specific ECM.
- Potential applications include organoid drug screening and implantable scaffolds.
- This approach enables the generation of personalized ECM for regenerative medicine.
